biote Corp.
biote Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -17,117 | 8.1 | -0.58 | -1.88 | 107.29 |
| Oct 2026 | -17,081 | 7.9 | -0.57 | -1.88 | 105.41 |
| Oct 2026 | -17,037 | 7.8 | -0.56 | -1.88 | 102.77 |
| Oct 2026 | -17,028 | 7.7 | -0.56 | -1.88 | 102.40 |
| Oct 2026 | -17,010 | 7.6 | -0.55 | -1.88 | 101.45 |
| Oct 2026 | -16,938 | 7.4 | -0.53 | -1.88 | 97.42 |
| Oct 2026 | -17,072 | 7.8 | -0.56 | -1.88 | 102.89 |
biote Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 44,232,000.0 | 44,935,000.0 | 46,408,000.0 | 47,956,000.0 |
| Net Profit | -6,563,000.0 | 2,277,000.0 | 1,954,000.0 | 8,188,000.0 |
| EPS | -0.2 | 0.1 | 0.1 | 0.3 |
biote Corp. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 192,219,000.0 | 197,191,000.0 | 185,360,000.0 | 164,957,000.0 | — |
| Net Profit | 27,045,000.0 | 3,157,000.0 | 3,316,000.0 | -969,000.0 | — |
| EPS | 0.9 | 0.1 | 0.1 | -0.1 | — |
biote Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 107,613,000.0 | 122,370,000.0 | 155,295,000.0 | 111,645,000.0 | — |
| Total Liabilities | 158,010,000.0 | 224,570,000.0 | 191,841,000.0 | 169,919,000.0 | — |
| Total Equity | -58,539,000.0 | -105,928,000.0 | -29,397,000.0 | -44,459,000.0 | — |
Owes vs Owns
biote Corp. owed $1.57 for every $1 it owned in Jun 2026, up from $1.52 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.57× | 1.47× | 1.84× | 1.24× | 1.52× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
biote Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
How it's funded — Dec 2025
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 24.1 | 39.3 | 89.0 | 79.2 |
| Receivables | 7.7 | 7.7 | 8.2 | 6.9 |
| Inventory | 19.1 | 14.8 | 17.3 | 11.2 |
| Fixed assets (tangible) | 13.5 | 10.2 | 3.1 | 3.6 |
| Intangible assets | 14.6 | 15.2 | 5.0 | 5.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 28.7 | 35.1 | 32.7 | 5.7 |
| Liabilities & equity | ||||
| Short-term debt | 6.2 | 6.2 | 6.2 | 6.2 |
| Long-term debt | 100.8 | 101.2 | 106.6 | 112.1 |
| Payables | 6.8 | 5.8 | 4.2 | 4.1 |
| Other liabilities | 44.2 | 111.3 | 74.8 | 47.5 |
| Shareholders' equity | -50.4 | -102.2 | -36.5 | -58.3 |
| Net tangible assets | -73.2 | -121.1 | -34.4 | -49.5 |
biote Corp. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 35,194,000.0 | 45,243,000.0 | 26,883,000.0 | -9,157,000.0 | — |
| Investing Activities | -6,864,000.0 | -18,798,000.0 | -2,713,000.0 | -1,838,000.0 | — |
| Financing Activities | -43,555,000.0 | -76,083,000.0 | -14,380,000.0 | 63,460,000.0 | — |